Table 1.
CTC count |
|||
All patients | Low (CTC ≤ 17) | High (CTC > 17) | |
n = 43 | n = 23 | n = 20 | |
Age | |||
Mean (range) | 64 (39-89) | 65 (39-89) | 64 (48-83) |
Sex | |||
Male | 32 (74.4) | 15 (65.2) | 20 (85.0) |
Female | 11 (25.6) | 8 (34.8) | 3 (15.0) |
ECOG | |||
0-1 | 36 (83.7) | 22 (95.6) | 14 (70.0) |
2-4 | 7 (16.3) | 1 (4.3) | 6 (30.0) |
Primary tumor location | |||
Distal oesophageal | 12 (27.9) | 8 (34.8) | 4 (20.0) |
Gastroesophageal junction | 14 (32.6) | 4 (17.4) | 10 (50.0) |
Gastric | 17 (37.5) | 11 (47.8) | 6 (30.0) |
Stage | |||
II | 18 (41.9) | 13 (56.5) | 5 (25.0) |
III | 6 (14.0) | 4 (17.4) | 2 (10.0) |
IV | 19 (44.2) | 6 (26.1) | 13 (65.0) |
CTC: Circulating tumor cell; ECOG: Eastern cooperative oncology group performance status.